Bioscience Notebook re Alexion and NanoViricides
Bioscience Notebook: Alexion has completed its acquisition of Achillion. NanoViricides stock soars re coronavirus fears…. more
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Bioscience Notebook: Alexion has completed its acquisition of Achillion. NanoViricides stock soars re coronavirus fears…. more
State Senator Christine Cohen and the Connecticut legislature’s Bioscience Caucus were briefed this week by a private-sector bioscience industry advocate and by the commissioner of Connecticut’s...
QCDx, a private biotech company based in Farmington, CT that has developed a breakthrough Circulating Tumor Cell (CTC) liquid biopsy from a simple blood draw,...
David Lehman, the state’s commissioner of economic and community development, said there will be a strong push to create hubs of innovation in industries such...
Connecticut Governor Ned Lamont has announced that the first proposals he is submitting to the Connecticut General Assembly during the 2020 legislative session will be a...
With the goal of identifying advanced treatment approaches for children with genetic orthopedic conditions, Shriners Hospitals for Children® and The Jackson Laboratory (JAX) have entered...
A prominent developer is proposing to build 500,000 square feet of laboratory and life-sciences incubation space in downtown New Haven. Winstanley Enterprises LLC plans a major...
Wellinks, a six-year-old New Haven startup founded by Yale students who invented an internet-connected brace-monitoring strap for scoliosis patients, has been acquired by Fairfield respiratory...
Two NIH-funded study programs at UConn School of Medicine are studying ways to promote HIV testing and to improve the lives of people living with...
Alexion Pharmaceuticals is planning to initiate a pivotal Phase 3 study of ULTOMIRIS® (ravulizumab) in amyotrophic lateral sclerosis (ALS). The 50-week global study, called CHAMPION-ALS,...